series-b
Stage
2
Investors
About
Valcare Medical develops minimally invasive transcatheter annuloplasty systems to treat mitral regurgitation and structural heart valve disease by restoring natural valve geometry.
Explore Valcare Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.